| abstract |
Provided herein are methods of using E-selectin antagonists for mobilizing cells from bone marrow, such as hematopoietic cells, hematopoietic stem and progenitor cells, leukocytes and malignant cells, and hematopoietic tumor cells. More specifically, methods are provided for mobilizing cells from bone marrow to peripheral blood vessels and tissues using E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers, and peptides. |